Skip to content

TTRX TTRX Net Income

Net Income at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$727.2M-10.1%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$1.42B-2,353%
Journey Medical Corporation logo
Journey Medical CorporationDERM
-$2.23M+45.2%
PTH
Pelthos Therapeutics Inc.PTHS
-$10.24M-420%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-$78.69M-46.3%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
-$11.3M+54.9%

Other financials

Income statement

See full
Operating income-$1.2M-224%
EPS (diluted)-$0.03-200%

Balance sheet

See full
Cash & equivalents$11.2M+613%
Total debt$6.0M
Total equity$6.1M+647%
Total assets$18.6M

Cash flow

See full
Operating cash flow-$1.6M-448%

Valuation

See full
Market cap$217.45M-17.7%
Enterprise value$212.24M

Returns & leverage

See full
Return on equity-118.8%
Debt / equity
Current ratio2.2×

Where this comes from

Reported directly by TTRX in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is TTRX's net income?
TTRX (TTRX) reported net income of -$970.97K in Q1 2026.
How has TTRX's net income changed year-over-year?
TTRX's net income decreased by 195.5% year-over-year, from -$328.55K to -$970.97K.
What does net income mean?
The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.